Pancreatic Hormone Transport: How Insulin & Glucagon Reach the Liver

Endocrine Route to the Liver

Pancreatic hormones do not travel via a dedicated portal. They enter the systemic circulation and reach the liver through the hepatic artery (oxygenated blood) and portal vein (nutrient-rich blood from gut/spleen/pancreas).

Stepwise Journey

1. Secretion: β-cells → insulin; α-cells → glucagon (into islet capillaries).
2. Pancreatic venous drainage: → splenic vein → portal vein → liver sinusoids (first-pass for insulin ~50% extracted).
3. Systemic spillover: Remaining insulin enters hepatic veins → IVC → heart → arterial circulation → hepatic artery → liver (second pass).
4. Receptor binding: Insulin receptor (tyrosine kinase) on hepatocytes → IRS/PI3K/Akt → GLUT2 translocation, glycogen synthesis, lipogenesis, gluconeogenesis suppression.
5. Glucagon receptor (GPCR) → cAMP/PKA → glycogenolysis, gluconeogenesis.

Physiological Significance

• First-pass hepatic extraction buffers portal insulin, protecting periphery from hypoglycemia.
• Portal insulin:glucagon ratio is the primary determinant of hepatic glucose output.
• Insulin resistance blunts hepatic insulin action → uncontrolled gluconeogenesis → fasting hyperglycemia.

Clinical Note

Injected insulin (subcutaneous) bypasses portal first-pass → peripheral hyperinsulinemia relative to portal – contributes to lipogenesis, weight gain. Emerging therapies (implantable pumps, hepatoselective analogs) aim to restore portal gradient.